NYR
Click for more information
2.00% 4.9¢ nyrada inc.

PCSK9 Patent

  1. RBx
    643 Posts.
    lightbulb Created with Sketch. 1002
    clock Created with Sketch.
    28/05/21
    13:32
    Post #: 53488796
    Not sure if this has already been reported ...

    Cardio Therapeutics received Notice of Allowance for their patent application Heterocyclic Inhibitors of PCSK9 on 6 April 2021. Patent grant will follow once formalities are completed.
    NYR Price at posting: 31.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
SKS SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
right-arrow Created with Sketch.
NEWS Hillcrest Energy Unveils Power Factor Correction Prototype to Meet Growing Demand
right-arrow Created with Sketch.
NEWS Buying smarter as baby boomers get boost
right-arrow Created with Sketch.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NYR (ASX) to my watchlist
(20min delay)
Last
4.9¢ 		Change
-0.001(2.00%) 		Mkt cap ! $8.928M
Open High Low Value Volume
5.1¢ 5.2¢ 4.6¢ $25.55K 511.9K

Buyers (Bids)

No. Vol. Price($)
1 25099 4.6¢
 

Sellers (Offers)

Price($) Vol. No.
4.9¢ 21383 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.